Craniofacial studies in chicken embryos confirm the pathogenicity of human FZD2 variants associated with Robinow syndrome
Disease Models & Mechanisms · 2024
DOI: 10.1242/dmm.050584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2024. Verfasst von Shruti S Tophkhane und 3 weiteren Autor:innen. Beteiligte Einrichtung: Life Sciences Institute and Faculty of Dentistry, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. Hauptthemen laut MEDLINE: Chondrogenesis, Craniofacial Abnormalities, Frizzled Receptors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Robinow syndrome is a rare disease caused by variants of seven WNT pathway genes. Craniofacial features include widening of the nasal bridge and jaw hypoplasia. We used the chicken embryo to test whether two missense human FZD2 variants (1301G>T, p.Gly434Val; 425C>T, p.Pro142Lys) were sufficient to change frontonasal mass development. In vivo, the overexpression of retroviruses with wild-type or variant human FZD2 inhibited upper beak ossification. In primary cultures, wild-type and variant human FZD2 significantly inhibited chondrogenesis, with the 425C>T variant significantly decreasing activity of a SOX9 luciferase reporter compared to that for the wild type or 1301G>T. Both variants also increased nuclear shuttling of β-catenin (CTNNB1) and increased the expression of TWIST1, which are inhibitory to chondrogenesis. In canonical WNT luciferase assays using frontonasal mass cells, the variants had dominant-negative effects on wild-type FZD2. In non-canonical assays, the 425C>T variant failed to activate the reporter above control levels and was unresponsive to exogenous WNT5A. This is the first single amino acid change to selectively alter ligand binding in a FZD receptor. Therefore, FZD2 missense variants are pathogenic and could lead to the altered craniofacial morphogenesis seen in Robinow syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Life Sciences Institute and Faculty of Dentistry, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
- Department of Molecular Biology and Biochemistry, Centre for Cell Biology, Development and Disease, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
ORCID-Profile: Shruti S Tophkhane, Esther M Verheyen, Joy M Richman
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Tophkhane, S. S., Fu, K., Verheyen, E. M., & Richman, J. M. (2024). Craniofacial studies in chicken embryos confirm the pathogenicity of human FZD2 variants associated with Robinow syndrome. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.050584
Vancouver
Tophkhane SS, Fu K, Verheyen EM, Richman JM. Craniofacial studies in chicken embryos confirm the pathogenicity of human FZD2 variants associated with Robinow syndrome. Disease Models & Mechanisms. 2024. doi:10.1242/dmm.050584
BibTeX
@article{Tophkhane2024,
author = {Tophkhane, Shruti S and Fu, Katherine and Verheyen, Esther M and Richman, Joy M},
title = {Craniofacial studies in chicken embryos confirm the pathogenicity of human FZD2 variants associated with Robinow syndrome},
journal = {Disease Models & Mechanisms},
year = {2024},
doi = {10.1242/dmm.050584}
}
EUVIMED